| # | Drug | Count |
|---|---|---|
| 0 | BLINATUMOMAB | 31 |
| 1 | METHOTREXATE SODIUM | 18 |
| 2 | METHOTREXATE | 16 |
| 3 | CYCLOPHOSPHAMIDE | 14 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 14 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 14 |
| 6 | DEXAMETHASONE | 13 |
| 7 | DEXAMETHASONE 1.5 MG | 13 |
| 8 | CYTARABINE | 9 |
| 9 | VENETOCLAX | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 1 | BLINATUMOMAB | 31 | 0.0029 |
| 2 | PLATINUM | 1 | 0.0019 |
| 3 | INOTUZUMAB OZOGAMICIN | 5 | 0.0017 |
| 4 | NELARABINE | 1 | 0.0010 |
| 5 | CLOFARABINE | 2 | 0.0009 |
| 6 | PONATINIB HYDROCHLORIDE | 4 | 0.0008 |
| 7 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 8 | MICAFUNGIN SODIUM | 4 | 0.0006 |
| 9 | CHLORAMBUCIL | 2 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 5 | 0.0017 |
| 1 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 2 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |
| 3 | BCL-2 Inhibitor [EPC] | 9 | 0.0001 |
| 4 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 21 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 18 | 0.0001 |
| 8 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |